Cell Biology and Cell Biophysics Programme, EMBL Heidelberg, Meyerhofstrasse 1, 69117 Heidelberg, Germany
(e-mail: david.stephens{at}bristol.ac.uk pepperko{at}embl-heidelberg.de )
Accepted 18 December 2001
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Procollagen, ER, COPII, Golgi, sorting
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Transport between the ER and the Golgi complex in mammalian cells is
thought to occur in small 60-80 nm transport vesicles that transport cargo
directly to the Golgi and/or by coalescence to form larger tubular-vesicular
transport complexes (TCs) mediating long-range transport along microtubules
(Lippincott-Schwartz et al.,
2000; Stephens and Pepperkok,
2001
). The vesicular coat complexes COPII and COPI are involved in
this transport step (Rothman and Wieland,
1996
; Sheckman and Orci, 1996). COPII mediates the selection of
cargo within the ER and the budding of vesicular or vesicular tubular
intermediates that form a nascent transport complex (TC). These subsequently
become coated with the COPI complex prior to transport towards the Golgi
apparatus in larger COPI-coated transport complexes
(Aridor et al., 1995
;
Shima et al., 1999
;
Stephens et al., 2000
). COPI
mediates the retrieval of ER-resident and other recycling proteins from
post-ER membranes back to the ER (Letourner et al., 1994;
Bannykh and Balch, 1998
).
The majority of work to date addressing export of secretory cargo from the
ER has focused on the sorting of transmembrane proteins that are believed to
directly engage coat proteins on their cytosolic face of the membrane for
selection into, and concentration within, newly forming transport carriers. In
particular, ts-045-G has been widely used as a model protein for these
studies, as it can be accumulated within the ER at 39.5°C and released as
a relatively synchronous wave of transport at the permissive temperature
31°C (Lippincott-Schwartz et al.,
2000; Stephens et al.,
2000
; Scales et al.,
1997
; Presley et al.,
1997
). Although this system is undoubtedly of much use in
elucidating the mechanisms and principles behind cargo exit from the ER, it
only represents one class of cargo, which is not a naturally occurring
mammalian protein. When one considers soluble cargo molecules like enzymes or
growth factors, it immediately becomes apparent that they cannot directly
engage COPII coat complexes on the ER membrane in the same way that
transmembrane proteins can, that is by virtue of sorting motifs in their
cytosolic parts (Nishimura and Balch,
1997
; Sevier et al.,
1999
). This raises the question of how these molecules are
efficiently exported from the ER. Is there a membrane receptor for each and
every soluble cargo molecule or do generic receptors exist for different
classes of cargo?
We have previously shown that small soluble secretory cargo in the form of
lumGFP [GFP translocated into the ER by virtue of a cleavable signal sequence
(Blum et al., 2000)] fills
tubules that emanate from the ER and translocate to the Golgi upon shifting
cells from a 15°C temperature block to 37°C. Importantly, we found
that ts-045-G was sequestered, apparently within these tubules, into distinct
domains that were COPI coated (Blum et al.,
2000
). This provided us with the first hint of possible cargo
segregation during ER-to-Golgi transport.
Quantitative EM data suggest that small soluble cargoes such as amylase and
chymotrypsinogen are not actually concentrated upon exit from the ER but at a
later stage during transport to the Golgi
(Martinez-Menarguez et al.,
1999). The simplest explanation for this is that they enter
nascent COPII transport vesicles passively and are not actively concentrated
into them. One would therefore expect these cargoes to be contained in the
majority of transport carriers exiting the ER. One must also consider
extremely large macromolecular cargoes. Do such large cargo complexes utilise
the same mechanisms for ER-to-Golgi transport as smaller soluble cargoes or
distinct ones? For example, newly synthesised monomeric polypeptide chains of
type I procollagen, pro
1 (I) are 1464 amino acids in length and are
believed to assemble into a continuous triple helical molecule of >300 nm
length (Bächinger et al.,
1982
; Tromp et al.,
1988
; Brodsky and Ramshaw,
1997
; Lamandé and
Bateman, 1999
). This rigid rod-like structure would clearly be too
large to fit into conventional 60-80 nm vesicles budding from the ER
(Rothman and Wieland, 1996
;
Schekman and Orci, 1996
). It
remains therefore unclear how such cargo is packaged into transport carriers
and how it is subsequently transport to and through the Golgi complex.
In order to address this question we have tagged procollagen with spectral variants of GFP and followed its transport from the ER to the Golgi complex in living cells. We show that procollagen is segregated at ER exit sites into transport complexes distinct from those carrying ts-O45-G and ERGIC53. Our data show that this segregation requires COPI function and demonstrate for the first time in mammalian cells a COPI-dependent pre-Golgi step.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cloning of PC-FP
A cDNA encoding human procollagen type I (1) (pro
1 (I)) was
obtained from the ATCC (ATCC number 95498) and cloned into pEGFPN2 (Clontech,
Heidelberg, Germany) using the unique EcoRI-EcoNI sites
within the coding region. The remaining coding sequence of pro
1 (I)
was amplified by PCR and cloned into the EcoNI-SalI sites of
the above clone to generate a full-length coding region as a GFP fusion
(PC-FP). This was subsequently subcloned using BglII-PstI
(using a PstI site that was included in the PCR primer) to pECFPN1
(Clontech, Heidelberg, Germany) to generate PC-CFP. The sequence amplified by
PCR was confirmed by sequencing. Wherever possible PC-GFP was used for
imaging; multi-label experiments were performed using PC-CFP. No difference
between the two was found in in any experiment. We therefore use the notation
PC-FP (procollagen-fluorescent protein) to describe these fusions
interchangeably.
Tissue culture
Vero cells (ATCC CCL81) were grown in MEM containing 10% foetal calf serum;
HeLa cells (provided by Michael Way, EMBL-Heidelberg) were grown in DMEM (Life
Technologies, Karlsruhe, Germany) containing 10% foetal calf serum. The HeLa
and Vero cells used in this study express also endogenous procollagen (pro
1 (I)) as detected using specific antibodies)
(Fisher et al., 1989
;
Fisher et al., 1995
). Similar
results were obtained using either cell line. Cells were plated 24-48 hours
prior to injection on live cell dishes (MatTek, Ashland, MA, USA). Cells were
injected and subsequently imaged in MEM without phenol red, supplemented with
30 mM HEPES, pH 7.4 and 0.5 g/l sodium bicarbonate. Microinjection was
performed as previously described (Shima
et al., 1999
; Stephens et al.,
2000
; Pepperkok et al.,
1993
). HeLa cells were transfected using Fugene6 (Roche, Mannheim,
Germany) according to the manufacturers instructions.
Expression of markers
PC-FP was injected at a concentration of 50 µg/ml into the nucleus of
either HeLa or Vero cells. 120-180 minutes after incubation at 37°C,
cycloheximide was added (100 µg/ml final concentration) and cells were
imaged with or without the addition of ascorbate-2-phosphate to a final
concentration of 50 µg/ml. This concentration was found to give the most
reproducible results with regard to the formation of PC-FP containing TCs and
rapid, synchronous transport to the Golgi and was not found to be detrimental
to cells during the time course of these experiments. Cells were also seen to
continue to divide when cultured in 50 µg/ml of ascorbate overnight, and
furthermore, this concentration has also previously been shown not to affect
cell proliferation, protein synthesis or carbohydrate synthesis
(Levene and Bates, 1975). All
experiments that did not involve PC-FP were also carried out in the presence
of the same concentration of ascorbate with no noticeable effects. Genuine
pre-Golgi TCs containing PC-FP were identified in all experiments (both using
live and fixed cells) by close inspection of cells expressing appropriately
low levels of PC-FP. This, coupled with the early time points following
ascorbate addition (10 minutes) that were used in the experiments described
here, enabled us to unequivocally identify preas opposed to post-Golgi
TCs.
Localisation of PC-FP and ts-045-G containing TCs was performed by
transfection of both markers (Stephens et
al., 2000), incubating cells at 39.5°C for 16 hours in the
absence of ascorbate followed by 30 minutes at 39.5°C in the presence of
ascorbate. Cells were subsequently incubated for 5 minutes at 32°C prior
to fixation and processing for immunofluorescence. To determine the effect of
anti-EAGE injection this procedure was reproduced with the exception that
ascorbate was added concomitantly with reduction of the temperature to
32°C. After 5 minutes at 32°C, cells were injected with anti-EAGE
(Pepperkok et al., 1993
) at a
concentration of 1.5 mg/ml. This enabled us to determine the effect of COPI
inhibition on TC dynamics as well as formation.
15°C temperature blocks were generated by incubating cells in a water
bath at 15°C in growth medium supplemented with 30 mM HEPES pH 7.4.
Expression of ARF1(Q71L) and SAR1a(H79G) mutants was
achieved by co-injection of plasmid DNA encoding the respective mutants with
DNA encoding the marker of interest. Anti-EAGE
(Pepperkok et al., 1993) was
injected at a concentration of 1.5 mg ml into the cytoplasm of cells
previously injected with plasmid DNA encoding PC-GFP or other markers.
Immunofluorescent labelling and microscopy
For immunofluorescence, cells were fixed using 3.5% paraformaldehyde,
permeabilised with 0.1% Triton X-100 and immunostained as described previously
(Stephens et al., 2000). The
antibodies used were as follows: anti-ERGIC-53 used at 1:50
(Schweizer et al., 1988
);
anti-BSTR (ß' COP) (Pepperkok
et al., 2000
) 1:500; CM1A10 (ß' COP)
(Palmer et al., 1993
), 1:1000.
Primary antibodies were detected using anti-mouse or anti-rabbit secondary
antibodies labelled with Cy3 or Cy5 as required. Living and fixed cells were
imaged using either an Olympus/TILL Photonics time-lapse microscope
(Stephens et al., 2000
) or
Leica DM/IRBE inverted microscope with a 63x, N.A. 1.4PL Apo objective
and individual custom filters from Chroma (Brattleboro, VT, USA) for GFP, CFP,
YFP, Cy3 and Cy5. Images were captured with a Hamamatsu CCD camera (ORCA-1)
using Openlab software (Improvision, Coventry, UK). Following acquisition,
images were converted to an image depth of 8 bit and processed using NIH
Image, Adobe Photoshop v6.0. QuickTime movies were generated using NIH Image,
QuickTime Pro and Adobe Premiere v5.1. Trajectories of particles and
velocities were determined using a macro written for NIH Image by Jens
Rietdorf (ALMF, EMBL, Heidelberg).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
It is important to note that cells expressing only low levels of
procollagen, 2 to 3 hours after microinjection of DNA, were used in the
experiments described here. At this point in each experiment, cycloheximide
was added to a final concentration of 100 µg/ml to prevent further protein
synthesis. After the addition of ascorbate, which is an essential co-factor of
prolyl hydroxylase that is required during the folding and assembly of PC
(Brodsky and Ramshaw, 1997;
Lamandé and Bateman,
1999
; Prockop and Kivirikko,
1995
), PC-FP redistributed (within 10 minutes) to small spherical
structures dispersed throughout the cytoplasm
(Fig. 1B,
Fig. 2B; arrowheads).
Time-lapse imaging revealed fast, directed transport of these structures along
curvi-linear tracks to the juxtanuclear region of the Golgi complex
(Fig. 1B, Fig. 2B; see Movie 2 at
jcs.biologists.org/supplemental
). Their speed ranged between 0.6 and 1.3 µm/s, and movement was blocked by
the microtubule disrupting drug nocodazole and overexpression of p50
(dynamitin, data not shown), which disrupts dyneinmediated transport
(Presley et al., 1997
;
Echeverri et al., 1996
),
suggesting that transport of PC-FP occurs along microtubules in a
dyneindynactin-dependent manner. 10 minutes after the addition of
ascorbate, PC-FP accumulated in the juxtanuclear Golgi region of the cells
(particularly apparent towards the end of Movie 2). At this time point, all
PC-FP TCs are seen to move towards the Golgi apparatus from the periphery (see
Movie 2) as would be expected for ER-to-Golgi transport intermediates.
Structures emanating from the Golgi moving towards the cell periphery were
first observed 30 minutes after the addition of ascorbate (not shown). At
later time points, 1-3 hours after ascorbate addition, PC-FP fluorescence
completely disappeared, consistent with its secretion from cells. The
experiments described here were focused upon characterisation of ER-to-Golgi
transport of procollagen, and therefore we undertook all experiments, unless
otherwise stated, 10 minutes after the addition of ascorbate to the culture
medium. In addition, all cells that were fixed and subsequently processed were
first inspected by microscopy to confirm trafficking of procollagen following
ascorbate addition. Thus, analysis of cells at time intervals of between 10
and 20 minutes after the addition of ascorbate provides us with a means to
identify bona fide ER-to-Golgi intermediates (TCs) and not post-Golgi
carriers. Note that the ER localisation of PC-FP is such that one sees a large
amount of fluorescence in the perinuclear area of the cell
(Fig. 1A,
Fig. 2A,
Fig. 6). This is necessary in
order to obtain good contrast of the peripheral ER network and does not
represent Golgi staining. Indeed, there is a considerable amount of ER
membrane in this area of these cells as evidenced by immunolabelling with
antibodies against well characterised ER markers such as PDI and also by live
cell imaging with ER-CFP (Stephens et al.,
2000
).
|
At higher levels of expression (>6 hours after injection), in the
absence of ascorbate, PC-FP was seen to aggregate into large spherical
structures still apparently bounded by the ER membrane
(Fig. 1C). These aggregates
completely disappear upon incubation with ascorbate for 3 hours but in a
nonsynchronous manner. Compared to TCs identified in cells expressing low
levels of PC-FP, these large structures contained at least 10-15 times more
PC-FP as adjudged by quantitation of fluorescence. Furthermore, these
structures were relatively immobile in cells, and long-range transport
(greater than 2 µm) was not observed. Therefore, these aggregate structures
could be clearly distinguished from PC-FP TCs. It is likely that these
aggregates represent previously described higher order structures of
procollagen and PDI, which form within the lumen of the ER
(Kellokumpu et al., 1997).
Indeed, these aggregate structures, unlike ER-to-Golgi TCs, were seen to label
with anti-PDI antibodies (data not shown), which is consistent with being part
of the ER. Cells expressing such high levels of PC-FP were not used in any of
the experiments described here.
In summary, these data show that PC-FP, when expressed at low levels, is
secreted from cells in an ascorbate-dependent manner and can thus be used as a
regulated ER-to-Golgi transport marker in living cells. Furthermore, it
behaves similarly, if not identically, to endogenous PC and is transported
from the ER to the Golgi complex in transport complexes (TCs) similar to those
described earlier for various membrane proteins
(Scales et al., 1997;
Presley et al., 1997
;
Chao et al., 1999
) and the
small soluble secretory cargo lumenal GFP
(Blum et al., 2000
).
TCs containing PC-FP segregate from COPI-coated TCs carrying ts-O45-G
and ERGIC-53
Previous work has shown that COPII does not remain associated with TCs in
transit to the Golgi apparatus (Stephens
et al., 2000) but is instead only detected in close proximity to
the ER membrane (Stephens et al.,
2000
; Hammond and Glick,
2000
). Since the behaviour of PC-FP TCs was similar to those
described earlier for ts-O45-G, we asked whether PC-FP also exits the ER via
COPII-coated ER exit sites and loses its COPII coat prior to transport to the
Golgi. Analysis of double colour timelapse image series
(Fig. 2C-J) showed that,
already 2 minutes after the addition of ascorbate, newly forming TCs
containing PC-FP could be observed forming from the ER network
(Fig. 2C,D, arrowheads). These
structures precisely coincide with YFP-SEC24Dp
(Fig. 2D, which is particularly
apparent in panels E and F, which show enlarged views of the region bounded by
the white box in C and D respectively), suggesting that newly forming PC-FP
TCs emerge from sites labelled with SEC24Dp-YFP
(Fig. 2G-J; SEC24Dp in red,
marked with an arrow; see also Movie 3 at
jcs.biologists.org/supplemental
). Subsequently (5 minutes after the addition of ascorbate), SEC24Dp-YFP and
PC-CFP segregated, and PC-CFP was transported to the Golgi independent of
COPII (Fig. 2G-J, arrowhead) as
previously described for ts-045-G
(Stephens et al., 2000
).
Immunostaining of fixed cells 10 minutes after the addition of ascorbate,
and identification of moving TCs by visual inspection, showed that the
majority of PC-FP TCs, which initially all moved towards the Golgi at this
time point, did not positively immunolabel with antibodies against either COPI
(Fig. 3A,B) or ERGIC-53
(Fig. 3C,D). This observation
was striking since it has previously been reported that the majority of
ts-045-G containing TCs en route to the Golgi complex do label for ß-COP
(Shima et al., 1999;
Griffiths et al., 1995
;
Pepperkok et al., 1998
) and
contain ERGIC-53 (Pepperkok et al.,
1998
), results which were confirmed in this study
(Fig. 4G-L;
Table 1). Quantitative analysis
showed that on average only 2% and 3.1% of the PC-FP TCs contained ERGIC-53 or
COPI, respectively (Table 1).
In contrast, at least 50% of ERGIC-53 structures contained COPI and vice versa
(data not shown) (Griffiths et al.,
1995
).
|
|
|
We also analysed the localisation of PC-FP and ts-045-G following release
of the two markers from the ER. Cells were transfected with plasmids encoding
both markers and were incubated at 39.5°C overnight to accumulate
ts-045-G-YFP in the ER. After 16 hours at 39.5°C, ascorbate and
cycloheximide were added to the culture medium for 30 minutes. Cells were then
incubated for 6 minutes at 32°C and fixed with paraformaldehyde. Under
these conditions, PC-FP was not efficiently transported out of the ER, and TCs
were not observed moving to the Golgi at 39.5°C. Only after shifting the
temperature to 32°C were TCs clearly identifiable and all moved towards
the Golgi showing that they are bona fide ER-to-Golgi transport intermediates.
Analysis of cells co-expressing PC-FP and ts-045-G-YFP showed that only 4.3%
of the PC-FP TCs contained ts-045-G-YFP during ER-to-Golgi transport
(Table 1). These TCs were also
positive, by immunolabelling, for COPI
(Fig. 4A-F). Control
experiments confirmed previously published reports
(Scales et al., 1997;
Pepperkok et al., 1998
) that
ts-045-G-labelled TCs also label for COPI (90.5%) and ERGIC-53 (56%)
(Fig. 4G-L;
Table 1). These results show
that PC-FP is transported from the ER to the Golgi complex in TCs that are
distinct from COPI-coated ER-to-Golgi TCs carrying ts-O45-G, ERGIC 53, lumenal
GFP (D.S. and R.P., unpublished) (see Blum et al.
(2000
)). This suggests that
mechanisms must exist to segregate PC-FP from ts-O45-G and other membrane
proteins. In order to address this problem we first asked where and when this
segregation takes place during ER-to-Golgi transport.
To examine the point of segregation of PC-FP from ERGIC-53, we incubated
cells at 15°C. At this temperature, ER-to-Golgi transport is arrested at a
very early stage following ER exit analogous to newly formed TCs
(Kuismanen et al., 1992;
Blum et al., 2000
). Cells
expressing PC-FP were incubated at 15°C for 60 minutes in the presence of
cycloheximide followed by the addition of ascorbate and a further incubation
at 15°C for 90 minutes. As can be seen in
Fig. 5, PC-FP
(Fig. 5A; arrows) did not
significantly overlap with ERGIC-53 (Fig.
5B; arrows) under these conditions. Similar results were obtained
when cells were incubated with ascorbate, coincident with the shift to
15°C, and when cells were first incubated in the presence of ascorbate at
37°C for 10 minutes prior to shifting to 15°C (both not shown). Thus,
PC-FP and ERGIC-53 are already segregated from one another when transport is
blocked at this early stage of the secretory pathway. Quantitation of these
experiments showed that only 4.1% and 2.9% of PC-FP containing structures at
15°C also contained ERGIC-53 or COPI respectively
(Fig. 5; Table 1). In contrast,
consistent with previous observations
(Griffiths et al., 1995
),
96.7% of COPI structures also contained ERGIC-53. We believe that these
results represent segregation of procollagen from ERGIC-53 upon or very
shortly after ER exit. Interestingly, a small but significant population of
COPII structures (on the average 12.7%)
(Table 1) that did not label
for ERGIC 53 at 15°C was consistently found, suggesting that they
represent a population of specialised COPII-coated ER exit sites
preferentially used by cargoes such as procollagen.
|
Anti-COPI antibodies inhibit transport of PC-FP and segregation from
ts-O45-G at ER exit sites
To investigate further at which level segregation of PC-FP from ts-O45-G
and other membrane proteins occurs we next investigated how transport of PC-FP
was dependent on the function of COPII or COPI. Co-expression of PC-FP with a
SAR1, a dominant-negative mutant (SAR1a(H79G)) that cannot
hydrolyse GTP (Aridor et al.,
1995; Kuge et al.,
1994
), followed by incubation with ascorbate, led to a complete
arrest of PC-FP within the ER (Fig.
6B) in contrast to the punctate distribution of PC-FP in TCs from
the same dish but injected with control IgG
(Fig. 6A, arrowheads). This
shows that export of PC-FP from the ER and the subsequent formation of PC-FP
TCs involves the function of the COPII complex.
COPI function was inhibited by expression of dominant-negative form of ARF1
(ARF1(Q71L)), the small GTP-binding protein responsible for the
recruitment of COPI to membranes (Zhang et
al., 1994; Dascher and Balch,
1994
). Expression of ARF1(Q71L) blocked PC-FP transport
(Fig. 6D). Interestingly, this
block also apparently occurred at the level of exit from the ER since PC-FP
was seen to retain its ER localisation after ascorbate treatment without any
significant formation of PC-FP TCs (Fig.
6D). This result was surprising, as previous work using ts-O45-G
as a transport marker showed that COPI was not directly involved in ER exit
and appearance of TCs (Shima et al.,
1999
; Scales et al.,
1997
; Pepperkok et al.,
1998
). A likely explanation for our results might be that the
inhibition of ER exit by ARF1(Q71L) was caused indirectly, through
inhibition of recycling of machinery back to the ER for example, because
ARF1(Q71L) was expressed 4-6 hours before treatment of cells with
ascorbate.
To address this problem, COPI function was inhibited by microinjection of
monovalent Fab fragments of an antibody that blocks COPI function
(anti-EAGE (Pepperkok et al.,
1993)). Anti-EAGE was microinjected either before or after
addition of ascorbate to the cells. Control experiments confirmed the efficacy
of anti-EAGE injection by blocking transport of ts-045-G-GFP (not shown).
Injection of anti-EAGE prior to the addition of ascorbate arrested PC-FP
within the lumen of the ER (Fig.
6F; Movie 4 at
jcs.biologists.org/supplemental
), similar to the effect of expression of ARF1(Q71L)
(Fig. 6D). This suggests a
function for COPI in the accumulation of PC-FP in nascent TCs. However,
injection 10 minutes after the addition of ascorbate led to a progressive but
not immediate inhibition of PC-FP transport
(Fig. 7A) (Movie 5 at
jcs.biologists.org/supplemental
). Only about 5% of the pre-existing PC-FP TCs were seen to be moving
immediately following injection of anti-EAGE. The remaining TCs were immobile
and apparently stable (Fig. 7A)
(Movie 3, showing 3 minutes of imaging). In contrast, in cells microinjected
with control antibodies, 40-50% of PC-FP TCs were mobile during the time frame
of the imaging (3 minutes) and indistinguishable in their behaviour from TCs
in non-injected cells (not shown). Indistinguishable results were obtained
with ts-O45-G GFP as the transport marker (not shown). At later time
points, 20-30 minutes after injection of anti-EAGE, all of the pre-existing,
PC-FP-containing TCs were seen to be immobile
(Fig. 7B), and the number of
PC-FP TCs compared with the control injected cells was significantly decreased
(Fig. 7B), suggesting that
anti-EAGE injection inhibits their formation. This is consistent with the
arrest of PC-FP in the ER when injection was performed before addition of
ascorbate (Fig. 6F).
|
These data show that COPI controls transport of both ts-O45-G and PC-FP at the ER exit level. This appears to be in contrast to our finding that PC-FP containing TCs are devoid of COPI en route to the Golgi complex. A simple explanation for this is that COPI is involved in a step that occurs shortly after COPII-dependent export from the ER, where COPI mediates the segregation of the two transport markers into distinct TCs at, or directly adjacent to, the ER exit site. If this was the case then injection of anti-EAGE should inhibit the segregation of PC-FP from ERGIC-53 at the ER exit level. Cells expressing PC-FP were incubated in the presence of cycloheximide and ascorbate. The total incubation time of the cells in ascorbate before injection of anti-EAGE was approximately 30 minutes, including transfer to the microscope, identification of cells expressing low levels of PC-FP in which Golgi-directed TCs could be identified and microinjection of anti-EAGE. Cells were then fixed and processed for immunofluorescence. In cells microinjected with anti-EAGE (Fig. 8C,D) segregation of PC-FP from ERGIC-53 was no longer apparent; 77.5% of PC-FP-labelled structures contained ERGIC-53. Overlap of PC-FP and ERGIC-53 is particularly evident in the insets to Fig. 8C and D (arrowheads) showing colocalisation of the markers within TCs lying directly adjacent to ER membranes. Cells injected with control IgG showed the same segregation of PC-FP TCs from ERGIC-53 immunostaining (Fig. 8A,B; arrows).
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The rapidity with which we observe transformation of PC-FP from a faint ER localisation to bright, uniform punctate TCs trafficking towards the Golgi complex suggests that active concentration processes exist to accumulate PC-FP prior to export from the ER. Such a selective recruitment into ER export sites could conceivably occur through membrane-anchored receptors or independently by some mechanism coupled to the assembly of the trimeric PC molecule. It seems logical that the most likely way in which PC-FP could engage the cytosolic COPII complex for concentration into export sites is by a membrane receptor. This receptor should interact with transport-competent PC-FP in the lumen of the ER and via its cytosolic tail with COPII units in the cytoplasm.
Type I procollagen is believed to assemble into a large rod-like structure
of approximately 330 nm (Bächinger et
al., 1982). This directly implies that the fully assembled PC
molecule would be too large to fit inside conventional 60-80 nm diameter COPII
transport vesicles (Rothman and Wieland, 1997; Sheckman and Orci, 1997). The
data presented here are, however, entirely consistent with COPII-dependent
exit of procollagen from the ER. We not only visualise PC-FP transport
complexes emerging from COPII-labelled ER exit sites but also find that
inhibition of COPII function arrests procollagen in the ER. Thus we propose
that COPII function is also required for the secretion of large soluble cargo
such as procollagen. Our data are consistent with proposed models of COPII
function in terms of cargo selection and membrane deformation but suggest now
that intermediates other than 60-80 nm vesicles may also be generated by the
action of the COPII complex on the ER membrane. An alternative explanation may
be that full assembly of type I procollagen occurs not in the ER but on the
level of post-ER transport complexes. In this case COPII vesicles would be
involved in ER exit of the unassembled PC, which subsequently gives rise to
the formation of PC-FP-containing TCs, where full assembly would take place.
The latter explanation we consider less likely because the consensus within
the literature tends towards a complete folding of procollagen prior to ER
exit (Brodsky and Ramshaw,
1997
; Lamandé and
Bateman, 1999
; Prockop and
Kivirikko, 1995
; Walmsley et
al., 1999
). This hypothesis is also entirely consistent with the
ascorbate-dependent exit of procollagen from the ER and the fact that
unassembled procollagen chains are degraded by the proteasome and not by
lysosomal enzymes (Fitzgerald et al.,
1999
).
The most striking result reported here is that procollagen is transported from the ER to the Golgi in transport complexes distinct from those containing ts-O45-G and ERGIC-53. These observations cannot be explained by different ER export kinetics alone for two reasons. Firstly, PC-FP-containing TCs do not contain ERGIC-53. ERGIC-53 is an itinerant ER-to-Golgi recycling protein and therefore should be present within all ER-to-Golgi Tcs at steady state regardless of the kinetics of formation of these TCs. Secondly, PC-FP TCs are also devoid of cytosolic, vesicular coat complex COPI, in contrast to ts-O45-G containing TCs. Therefore, we propose the existence of at least two cargo transport pathways from the ER to the Golgi, one taken by PC-FP and one by ts-045-G and ERGIC-53. It appears that ts-O45-G and PC-FP are concentrated in the same or close by ER exit sites and segregation of the two markers occurs subsequently. This then immediately raises the question of where exactly and how does segregation of the two pathways take place.
Our data show that COPI is directly or indirectly involved at an early step
close to ER exit. Injection of anti-COPI antibodies results in a progressive
inhibition of both PC- and ts-O45-G-labelled TC movement and the appearance of
new TCs at ER exit sites. Coincident with this, colocalisation of PC-FP with
ERGIC-53 at ER exit sites is enhanced. Furthermore, injection of antibodies
before addition of ascorbate or expression of constitutively active ARF1
mutant results in arrest of procollagen in the ER. These findings appear to be
in contrast to our observations that COPI is absent from PC-FP TCs en route to
the Golgi complex. However, a simple explanation for this is that cargo is
sorted in a COPI-dependent manner at the level of TC formation adjacent to the
ER membrane. Thus, inactivation of COPI would inhibit segregation of PC from
ts-O45-G and other markers as we observed it here. This hypothesis is also
consistent with earlier findings suggesting that COPI has a direct and early
function in the biogenesis of nascent TCs
(Aridor et al., 1995;
Lavoie et al., 1999
). An
alternative hypothesis would be that inhibition of COPI function allows fusion
of previously distinct carriers containing either procollagen or ERGIC-53.
Another mechanism of segregation, although less likely, could be one in
which other secretory cargo are segregated from procollagen en route to the
Golgi, analogous to the formation of secretory granules in which components of
immature secretory granules are removed in a clathrin-dependent process during
maturation (Tooze, 1998).
Observations along this line have been made earlier demonstrating that
ts-O45-G-containing TCs establish an anterograde-cargo-rich (ts-O45-G) and
retrograde-cargo-rich (ERGIC-53, and COPI) domain en route to the Golgi in a
COPI-dependent manner (Shima et al.,
1999
). Therefore, one could speculate that PC-FP and ts-O45-G were
segregated on moving TCs by a distinct but similar COPI-dependent mechanism.
However, the absence of dual labelled structures (PC-FP and ts-O45-G),
described here for all time points upon separation of respective TCs from the
ER, argues against this. Furthermore, when ER-to-Golgi transport was arrested
at 15°C, segregation of ERGIC-53- and PC-FP-containing TCs was already
complete, in contrast to the observations made by Shima et al.
(Shima et al., 1999
) where
domain segregation occurred after the 15°C transport block. Furthermore,
the segregation of cargoes observed here is unlikely to be a result of
differential localisation within a single structure owing to the large
distances (2-5 µm) typically observed between PC-FP and ERGIC-53 containing
TCs (Fig. 3).
Our observations here are entirely consistent with recent data obtained
from experiments using the yeast Saccharomyces cerevisiae showing
that different cargo molecules can be sorted into different COPII vesicle
populations following exit from the endoplasmic reticulum
(Muñiz et al., 2001).
Whether the process described by Muñiz et al.
(Muñiz et al., 2001
)
represents COPII-mediated sorting of components as opposed to lateral
segregation of GPI-anchored proteins from others within the lipid bilayer
remains unclear. A further important point is that the entire ER in S.
cerevisiae appears to act as transitional ER facilitating the generation
of COPII-coated vesicles (Rossanese et
al., 1999
). In contrast, the transitional ER of mammalian cells is
organised into discrete ER export sites
(Stephens et al., 2000
;
Hammond and Glick, 2000
). This
functional distribution would make it easier to have a simple partitioning of
GPI-anchored proteins from others within the ER membrane in S.
cerevisiae followed by COPII-mediated budding. Our data here suggest that
there is a COPI-mediated sorting event that occurs during or shortly after
exit from the ER. Together this suggests there may be more than one mechanism
for pre-Golgi protein sorting in operation.
The presence of distinct transport complexes containing ts-O45-G or
procollagen en route to the Golgi complex provides evidence for pre-Golgi
sorting in mammalian cells. It is presently unclear to what extent the
ts-O45-G- and procollagen-containing transport complexes are also different in
their morphology at the ultrastructural level. More work combining the light
microscopy approach used here with electron microscopy techniques will be
necessary to address this point (e.g.
Mironov et al., 2000). It is
also unclear why pre-Golgi sorting must occur. It is possible that segregation
within the Golgi provides a means for the differential glycosylation of
proteins that might otherwise receive identical modifications.
Three-dimensional reconstruction of Golgi structure shows that there exist
regions of cisternal Golgi interconnected with bridging tubules
(Ladinsky et al., 1999
),
providing a basis for continued segregation of proteins once TCs have reached
the Golgi. The hypothesis presented by Ladinsky et al.
(Ladinsky et al., 1999
) that
TCs fuse homotypically to form the first Golgi cisternae may provide a
mechanism by which this segregation is maintained. One possibility is that an
alternative ER-to-Golgi pathway exists for large protein complexes only.
Pre-Golgi sorting could occur for some cargo molecules like procollagen, algal
scale structures and aggregated protein complexes, which are too big to enter
small transport vesicles, or that need to take special routes through the
Golgi complex (Melkonian et al.,
1991
; Bonfanti et al.,
1999
; Volchuk et al.,
2000
). Alternatively, pre-Golgi sorting may represent the first
step in functional segregation and compartmentalisation of proteins within the
cell. In this context it will be important to determine whether the sorting of
different secretory proteins from one another before they reach the Golgi is
maintained during transport through the Golgi itself. Careful examination of
the distribution and lateral mobility of secretory cargo proteins within the
Golgi may enable us to address this question in the future.
![]() |
Acknowledgments |
---|
![]() |
Footnotes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aridor, M., Bannykh, S. I., Rowe, T. and Balch, W. E. (1995). Sequential coupling between COPII and COPI vesicle coats in endoplasmic reticulum to Golgi transport. J. Cell Biol. 131,875 -893.[Abstract]
Bächinger, H. P., Doege, K. J., Petschek, J. P., Fessler,
L. I. and Fessler, J. H. (1982). Structural implications from
an electron microscopic comparison of procollagen V with procollagen I,
pC-collagen I, procollagen IV, and a Drosophila procollagen.
J. Biol. Chem. 257,14590
-14592.
Bannykh, S. I. and Balch, W. E. (1998). Selective transport of cargo between the endoplasmic reticulum and Golgi compartments. Histochem. Cell Biol. 109,463 -475.[Medline]
Blum, R., Stephens, D. J. and Schulz, I.
(2000). Lumenal targeted GFP, used as a marker of soluble cargo,
visualises rapid ERGIC to Golgi traffic by a tubulo-vesicular network.
J. Cell Sci. 113,3151
-3159.
Bonfanti, L., Mironov, A. A., Jr, Martinez-Menarguez, J. A., Martella, O., Fusella, A., Baldassarre, M., Buccione, R., Geuze, H. J., Mironov, A. A. and Luini, A. (1999). Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturation. Cell 95,993 -1003.
Brodsky, B. and Ramshaw, J. A. (1997). The collagen triple-helix structure. Matrix Biol. 15,545 -554.[Medline]
Chao, D. S., Hay, J. C., Winnick, S., Prekeris, R., Klumperman,
J. and Scheller, R. H. (1999). SNARE membrane trafficking
dynamics in vivo. J. Cell Biol.
144,869
-881.
Dascher, C. and Balch, W. E. (1994). Dominant
inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and
trigger disassembly of the Golgi apparatus. J. Biol.
Chem. 269,1437
-1448.
Echeverri, C. J., Paschal, B. M., Vaughan K. T. and Vallee, R. B. (1996). Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J. Cell Biol. 132,617 -633.[Abstract]
Fisher, L. W., Stubbs, J. T. 3rd and Young, M. F. (1995). Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. (Suppl) 266,61 -65.
Fisher, L. W., Termine, J. D. and Young, M. F.
(1989). Deduced protein sequence of bone small proteoglycan I
(biglycan) shows homology with proteoglycan II (decorin) and several
nonconnective tissue proteins in a variety of species. J. Biol.
Chem. 264,4571
-4576.
Fitzgerald, J., Lamande, S. R. and Bateman, J. F.
(1999). Proteasomal degradation of unassembled mutant type I
collagen pro-alpha1(I) chains. J. Biol. Chem.
274,27392
-27398.
Griffiths, G. and Simons, K. (1986). The trans Golgi network: sorting at the exit site of the Golgi complex. Science 234,438 -443.[Medline]
Griffiths, G., Pepperkok, R., Locker, J. K. and Kreis, T. E.
(1995). Immunocytochemical localization of beta-COP to the
ER-Golgi boundary and the TGN. J. Cell Sci.
108,2839
-2856.
Hammond, A. T. and Glick, B. S. (2000).
Dynamics of transitional endoplasmic reticulum sites in vertebrate cells.
Mol. Biol. Cell 11,3013
-3030.
Jiminez, S. A., Bashey, R. I., Benditt, M. and Yanowski, R. (1977). Identification of a1(I) collagen trimer in embryonic chick tendons and calvaria. Biochem. Biophys. Res. Commun. 78,1354 -1361.[Medline]
Keller, P. and Simons, K. Post-Golgi biosynthetic
trafficking. (1997). J. Cell Sci.
110,3001
-3009.
Keller, P., Toomre, D., Diaz, E., White, J. and Simons, K. (2001). Multicolour imaging of post-Golgi sorting and trafficking in live cells. Nat. Cell Biol. 3, 140-149.[Medline]
Kellokumpu, S., Suokas, M., Risteli, L. and Myllyla, R.
(1997). Protein disulfide isomerase and newly synthesized
procollagen chains form higher-order structures in the lumen of the
endoplasmic reticulum. J. Biol. Chem.
272,2770
-2777.
Kuge, O., Dascher, C., Orci, L., Rowe, T., Amherdt, M., Plutner, H., Ravazzola, M., Tanigawa, G., Rothman, J. E. and Balch, W. E. (1994). Sar1 promotes vesicle budding from the endoplasmic reticulum but not Golgi compartments. J. Cell Biol. 125, 51-65.[Abstract]
Kuismanen, E., Jantti, J., Makiranta, V. and Sariola, M. (1992). Effect of caffeine on intracellular transport of Semliki Forest virus membrane glycoproteins. J. Cell Sci. 102,505 -513.[Abstract]
Ladinsky, M. S., Mastronard, D. N., McIntosh, J. R., Howell, K. E. and Staehelin, L. A. (1999). Golgi structure in three dimensions: functional insights from the normal rat kidney cell. J. Cell Biol. 144,135 -149.
Lamandé, S. R. and Bateman, J. F. (1999). Procollagen folding and assembly: the role of endoplasmic reticulum enzymes and molecular chaperones. Semin. Cell Dev. Biol. 10,455 -464.[Medline]
Lavoie, C., Paiement, J., Dominguez, M., Roy, L., Dahan, S.,
Gushue, J. N. and Bergeron, J. J. (1999). Roles for
alpha(2)p24 and COPI in endoplasmic reticulum cargo exit site formation.
J. Cell Biol. 146,285
-299.
Letourneur F., Gaynor E. C., Hennecke S., Demolliere C., Duden R., Emr S. D., Riezman H. and Cosson, P. (1994). Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum. Cell 79,1199 -1207.[Medline]
Levene, C. I. and Bates, C. J. (1975). Ascorbic acid and collagen synthesis in cultured fibroblasts. Ann. NY Acad. Sci. 258,288 -306.[Medline]
Lippincott-Schwartz, J., Roberts, T. H. and Hirschberg, K. (2000). Secretory protein trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol. 16,557 -589.[Medline]
Martinez-Menarguez, J. A., Geuze, H. J. Slot, J. W. and Klumperman, J. (1999). Vesicular tubular clusters between the ER and Golgi mediate concentration of soluble secretory proteins by exclusion from COPI-coated vesicles. Cell 98, 81-90.[Medline]
Melkonian, M., Becker, B. and Becker D. (1991). Scale formation in algae. J. Electron Microsc. Tech. 17,165 -178.[Medline]
Mironov, A. A., Polishchuk, R. S. and Luini, A. (2000). Visualizing membrane traffic in vivo by combined video fluorescence and 3D electron microscopy. Trends Cell Biol. 10,349 -353.[Medline]
Muñiz, M., Morsomme, P. and Riezman, H. (2001). Protein sorting upon exit from the endoplasmic reticulum. Cell 104,313 -20[Medline]
Müsch, A., Xu, H., Shields, D. and Rodriguez-Boulan, E. (1996). Transport of vesicular stomatitis virus to the cell surface is signal mediated in polarized and nonpolarized cells. J. Cell Biol. 133,543 -558.[Abstract]
Nishimura, N. and Balch, W. E. (1997). A
di-acidic signal required for selective export from the endoplasmic reticulum.
Science 277,556
-558.
Palmer, D. J., Helms, J. B., Beckers, C. J., Orci, L. and
Rothman, J. E. (1993). Binding of coatomer to Golgi membranes
requires ADP-ribosylation factor. J. Biol. Chem.
268,12083
-12089.
Pepperkok, R., Scheel, J., Horstmann, H., Hauri, H. P., Griffiths, G. and Kreis, T. E. (1993). Beta-COP is essential for biosynthetic membrane transport from the endoplasmic reticulum to the Golgi complex in vivo. Cell 74, 71-82.[Medline]
Pepperkok R., Lowe M., Burke B. and Kreis T. E.
(1998). Three distinct steps in transport of vesicular stomatitis
virus glycoprotein from the ER to the cell surface in vivo with differential
sensitivities to GTP gamma S. J. Cell Sci.
111,1877
-1888.
Pepperkok R., Lowe M., Burke B. and Kreis T. E.
(2000). COPI vesicles accumulating in the presence of a GTP
restricted Arf1 mutant are depleted of anterograde and retrograde cargo.
J. Cell Sci. 113,135
-144.
Presley, J. F., Cole, N. B., Schroer, T. A., Hirschberg, K., Zaal, K. J. and Lippincott-Schwartz, J. (1997). ER-to-Golgi transport visualized in living cells. Nature 389, 81-85.[Medline]
Prockop, D. J. and Kivirikko, K. I. (1995). Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64,403 -434.[Medline]
Rossanese, O. W., Soderholm, J., Bevis, B. J., Sears, I. B.,
O'Connor, J., Williamson, E. K. and Glick, B. S. (1999).
Golgi structure correlates with transitional endoplasmic reticulum
organization in Pichia pastoris and Saccharomyces cerevisiae.J. Cell Biol. 145,69
-81.
Rothman, J. E. and Wieland, F. T. (1996). Protein sorting by transport vesicles. Science 272,227 -234.[Abstract]
Scales, S. J., Pepperkok, R. and Kreis, T. E. (1997). Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI. Cell 90,1137 -1148[Medline]
Schweizer, A., Fransen, J. A., Bachi, T., Ginsel, L. and Hauri, H. P. (1988). Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J. Cell Biol. 107,1643 -1653.[Abstract]
Sevier, C. S., Weisz, O. A., Davis, M. and Machamer, C. E.
(1999). Efficient export of the vesicular stomatitis virus G
protein from the endoplasmic reticulum requires a signal in the cytoplasmic
tail that includes both tyrosine-based and di-acidic motifs. Mol.
Biol. Cell 11,13
-22.
Schekman, R. and L. Orci. (1996). Coat proteins and vesicle budding. Science 271,1526 -1533.[Abstract]
Shima, D. T., Scales, S. J., Kreis, T. E. and Pepperkok, R. (1999). Segregation of COPI-rich and anterograde-cargo-rich domains in endoplasmic-reticulum-to-Golgi transport complexes. Curr. Biol. 9,821 -824.[Medline]
Stephens, D. J., Lin-Marq, N., Pagano, A., Pepperkok, R. and
Paccaud, J.-P. (2000). COPI coated ER-to-Golgi transport
complexes segregate from COPII at ER exit sites. J. Cell
Sci. 113,2177
-2185.
Stephens, D. J. and Pepperkok, R. (2001).
Illuminating the secretory pathway: where do we need vesicles? J.
Cell Sci. 114,1053
-1059.
Tooze, S. A. (1998). Biogenesis of secretory granules in the trans-Golgi network of neuroendocrine and endocrine cells. Biochim. Biophys. Acta. 1404,231 -244.[Medline]
Tromp, G., Kuivaniemi, H., Stacey, A., Shikata, H., Baldwin, C. T., Jaenisch, R. and Prockop, D. J. (1988). Structure of a full-length cDNA clone for the prepro alpha 1(I) chain of human type I procollagen. Biochem. J. 253,919 -922.[Medline]
Volchuk, A., Amherdt, M., Ravazzola, M., Brugger, B., Rivera, V. M., Clackson, T., Perrelet, A., Sollner, T. H., Rothman, J. E. and Orci, L. (2000). Megavesicles implicated in the rapid transport of intracisternal aggregates across the Golgi stack. Cell 102,335 -348.[Medline]
Walmsley, A. R., Batten, M. R., Lad, U. and Bulleid, N. J.
(1999). Intracellular retention of procollagen within the
endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J. Biol.
Chem. 274,14884
-14892.
Zhang, C. J., Rosenwald, A. G., Willingham, M. C., Skuntz, S., Clark, J. and Kahn, R. A. (1994). Expression of a dominant allele of human ARF1 inhibits membrane traffic in vivo. J. Cell Biol. 124,289 -300.[Abstract]